Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard L Parnes

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
JAMA|July 7, 2005
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lowerIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
The Journal of Urology|May 15, 2007
Finasteride decreases the risk of prostatic intraepithelial neoplasiaIan M Thompson, M Scott Lucia, Mary W Redman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2015
Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialSarah H Nash, Cathee Till, Xiaoling Song, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2010
Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention TrialMarian L Neuhouser, Cathee Till, Alan Kristal, et al.
The New England Journal of Medicine|August 16, 2013
Long-term survival of participants in the prostate cancer prevention trialIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionM Scott Lucia, Amy K Darke, Phyllis J Goodman, et al.
Journal of the National Cancer Institute|April 20, 2006
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
JAMA|July 7, 2005
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lowerIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
The Journal of Urology|May 15, 2007
Finasteride decreases the risk of prostatic intraepithelial neoplasiaIan M Thompson, M Scott Lucia, Mary W Redman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2015
Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialSarah H Nash, Cathee Till, Xiaoling Song, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2010
Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention TrialMarian L Neuhouser, Cathee Till, Alan Kristal, et al.
The New England Journal of Medicine|August 16, 2013
Long-term survival of participants in the prostate cancer prevention trialIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionM Scott Lucia, Amy K Darke, Phyllis J Goodman, et al.
Journal of the National Cancer Institute|April 20, 2006
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Pageof 11